Contrast enhanced ultrasound a novel technique in lymphatic imaging – A Prospective study

Olli Lahtinen0 个研究点目标入组 160 人开始时间: 2020年5月20日最近更新: 2020年7月13日

适应症

试验速览

暂无简介。

•1st branch: 50 healthy volunteers with no prior upper arm surgery
•2nd branch: 50 consecutive patients with known history of breast cancer or upper arm melanoma with possible known lymphedema.
•3rd branch: 30 patients with prior history of breast cancer and possible lymphedema. All consecutive breast cancer patients having traditional lymphoscintigraphy as a part of their standard imaging are also recruited for this branch.
•4th branch: 30 consecutive patients with newly diagnosed vulvar cancer to whom sentinel biopsy will be scheduled.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 100
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 60

•1) Vulvar carcinoma patients who won’t have traditional lymphoscintigraphy (branch 4) 2) Vulvar carcinoma patients with prior lymphadenectomy in the groin area (branch 4) 3) People with egg allergy (all branches) 4) Patients to whom gadolinium contrast agent is contraindicated (branch 3) 5) Patients who have claustrophobia and can’t enter the MRI (branch 3). 6) Patients who have foreign material in their body which is contraindicated for MRI

发起方

Olli Lahtinen